Last reviewed · How we verify
NCT05756712
The Efficacy of White Kidney Bean on Oral Glucose Tolerance Test
NA trial testing Phase 1 Wonderlab Product in Diabetes in 34 participants. Completed in 31 March 2023.
15 March 2023
Quick facts
| Lead sponsor | Shenzhen Precision Health Food Technology Co. Ltd., |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | double |
| Primary purpose | supportive care |
| Enrollment | 34 |
| Start date | 6 March 2023 |
| Primary completion | 15 March 2023 |
| Estimated completion | 31 March 2023 |
| Sites | 1 location across China |
Drugs / interventions tested
- Phase 1 Wonderlab Product
- Phase 1 Placebo
- Phase 2 Placebo
- Phase 2 Wonderlab Product
Conditions studied
- Diabetes — all drugs for Diabetes →
- Sugar; Blood, High — all drugs for Sugar; Blood, High →
Sponsor
Shenzhen Precision Health Food Technology Co. Ltd.,
Who can join
Adults 25 to 45, any sex, with Diabetes or Sugar; Blood, High. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this randomized, double-blind, cross-over inverventional study is to evaluate the efficacy of white kidney bean on OGTT (oral glucose tolerance test). About 34 eligible participants will be randomized in two groups of the same size to take the assigned interventions at one study site in Shanghai, two visits will be required. The first group of participants will take Wonderlab product first and then placebo product after 72 hours of washout period, while the other group of of participants will take placebo product first and then Wonderlab product after 72 hours of washout period. For each visit, the finger blood will be sampled and the relevent data such as blood glucose will be captured based on OGTT procedures, and recorded into clinical data management system for statistical analysis. Researchers will compare the two groups to see if there is significant change of blood glucose by using products containing ingredient of white kidney beans.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05756712
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Diabetes
Currently open trials in the same condition.
- NCT07272837 — Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass · recruiting
- NCT07479134 — Production of Stem Cells for the Generation of Pancreatic Cells · NA · recruiting
- NCT07441655 — Families Implementing Good Health Traditions for Life · NA · recruiting
- NCT06724172 — CHIME: Comparing Health Interventions for Maternal Equity · NA · recruiting
- NCT07417865 — ECHO Diabetes FQHC · recruiting
Other Shenzhen Precision Health Food Technology Co. Ltd., trials
Trials by the same sponsor.
- NCT06030999 — The Prevention And Treatment On Obesity And Weight Management By Oral Supplementation Of Probiotics And Prebiotics · NA · completed
- NCT05900752 — A Multi-Strain Probiotic Reduces the Frequency of Diarrhea in IBS-D Patients · NA · completed
- NCT05696938 — Improved Skin Whitening Outcomes Associated With Nicotinamide Fortified Consumption in 30 to 50- Year-old Women · NA · completed
- NCT05710055 — The Efficacy on Overweight With Oral Supplemenation of Probiotics and Prebiotics · NA · completed
- NCT05682092 — Study of Collagen Efficacy on Skin Anti-aging in 30 to 50-Year-Old Women · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05756712 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Shenzhen Precision Health Food Technology Co. Ltd.,
- Last refreshed: 4 April 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05756712.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing